InspireMD announces CGuard clinical trial presentations at VEITHsymposium
NSPR•InspireMD said its CGuard and CGuard Prime stents will feature at VEITHsymposium in New York City from November 17-21, 2026. Presentations on November 20 will cover C-GUARDIANS II primary endpoint results, the ongoing C-GUARDIANS III trial and three-year follow-up data from 621 asymptomatic patients in the CGUARDIANS trial.
1. Presentations on November 20
InspireMD said presentations at VEITHsymposium will cover C-GUARDIANS II primary endpoint results and the status of the ongoing C-GUARDIANS III trial. Three-year follow-up data from 621 asymptomatic patients in the CGUARDIANS trial will also be presented.




